|Day Low/High||3.98 / 4.33|
|52 Wk Low/High||4.01 / 26.73|
Investors in Tekmira Pharmaceuticals Corp saw new options become available today, for the December 12th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TKMR options chain for the new December 12th contracts and identified one put and one call contract of particular interest.
Investors in Tekmira Pharmaceuticals Corp saw new options begin trading today, for the December 5th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TKMR options chain for the new December 5th contracts and identified one put and one call contract of particular interest.
Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a "perilous reversal" (up big yesterday but down big today) candidate
Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a pre-market mover with heavy volume candidate
Commences Manufacture of New RNAi Therapeutic for Ebola - Guinea Variant
Shares of Sarepta Therapeutics are soaring this morning following the publication of Phase I clinical study results for its Ebola and Marburg virus drug candidates.
Demonstrates Robust Knockdown of HBV Surface Antigen
Shares of companies leveraged to Ebola are rising again after a second health care worker in the U.S. tested positive for the illness.
Tekmira's LNP Technology Enables Treatment With Favorable Tolerability Profile for a Period of Up to One Year
The trading panel discussed defensive trades, the state of the market and whether Carl Icahn is right about Apple.
Shares of Lakeland Industries, which supplies protective clothing to the Centers for Disease Control and other governmental agencies, are soaring amid continued fears over the Ebola outbreak...
Stocks popped at the release of the FOMC minutes.
The trading panel discusses energy and retail stocks, as well as whether the market has further downside ahead. GM CEO Mary Barra, a guest, talked about GM's future.
U.S. stocks popped on Wednesday after the release of the Federal Reserve minutes which allayed fears an interest rate hike could come sooner than expected.
The Ebola outbreak has put the spotlight on Chimerix as well as other biotech companies with potential vaccines and even those stocks with marginal relation to the virus.
Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a strong on high relative volume candidate
Tekmira shares surge after Thomas Duncan's death announced.
The trading panel discusses Yum! Brands, the mining industry and Ebola treatments.
The trading panel discussed what other companies would benefit by splitting themselves and the extent of cyber crime.
Tekmira Pharmaceuticals (TKMR) shares are down double digits after having its rating downgraded to 'market perform' by analysts at Leerink Swann.
Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a weak on high relative volume candidate
The trading panel discussed emerging markets, volatility and how to trade on the dollar.
The U.S. is stronger than we thought, Cramer says, but will it last?
Tekmira Pharmaceuticals (TKMR) shares had their price target raised to $31 by analysts at Maxim Group on Friday.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.